Concepedia

Fang Qiu

FQ

Statistics

Publications

2

Citations

70

H-Index

2

Active since

2022

Affiliations

First Hospital of China Medical University(Current)

China Medical University

Anshan Hospital

Jiangsu Hengrui Medicine (China)

Affiliated Zhongshan Hospital of Dalian University

Fang Qiu is an author at First Hospital of China Medical University specializing in cancer pharmacology, breast cancer pharmacotherapy, and neoadjuvant chemotherapy.

ORCID

Publications per year

2022–2024

2

Publications

2

A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer

Nan Niu, Fang Qiu, Qianshi Xu et al. · Nature Communications · 2022 · 55 citations · Full text

, , +17

A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple‐positive breast cancer

Shiwen Huo, Jinqi Xue, Shuo Wang et al. · MedComm · 2024 · 15 citations · Full text

, , +17

1–2 of 2